安世控制权争夺持续：荷兰法庭激辩，闻泰力证“资产掏空”等指控不实

Core Viewpoint - The ongoing control dispute over Nexperia, a semiconductor company, involves its current temporary European management and its sole shareholder, China's Wingtech Technology, with a court hearing scheduled for January 14, 2026 [1] Group 1: Control Dispute Background - The dispute traces back to late September to early October 2025, when the Dutch Ministry of Economic Affairs issued a ministerial order that temporarily "froze" Nexperia's operations, leading to a court ruling that suspended CEO Zhang Xuezheng's position and limited Wingtech's control [1] - Despite the Dutch government's withdrawal of the ministerial order, the court's ruling remains effective, resulting in a deadlock over the company's control [1] Group 2: Allegations Against Wingtech - The allegations against Wingtech and its principal Zhang Xuezheng center on two main issues: "asset stripping" and "technology transfer" [2] - Wingtech's rebuttal indicates that Nexperia held approximately $396 million in its accounts at the time of the alleged "interference," contradicting the asset stripping claims [2] - Wingtech argues that internal discussions regarding "Project Haven," "Project X," and a second brand plan were merely preliminary responses to supply chain risks and were never implemented due to feasibility issues [2] Group 3: Knowledge and Technology Transfer Allegations - Wingtech refutes claims of "intellectual property theft" and "capacity transfer," asserting that Nexperia's market success does not rely on exclusive technology, as many core technologies are widely available or can be licensed [3] - The establishment of WSS was primarily to address Nexperia's capacity bottlenecks and supply chain pressures, with WSS investing approximately 12 billion RMB (over $1.7 billion) in factory construction, which Wingtech claims is independent of asset transfer motives [3] Group 4: Strategic Transformation and Governance Conflict - The governance conflict stems from strategic transformations initiated by Wingtech after acquiring Nexperia, which had previously struggled with insufficient R&D investment and slow growth [4] - Following the acquisition, Nexperia's revenue grew from approximately $1.43 billion in 2020 to $2.06 billion in 2024, with net profit increasing from $103 million to $331 million during the same period [4] - R&D expenditures rose from about $63 million in 2019 to $156 million in 2024, with a significant increase in patent applications, indicating a shift towards systematic innovation [4] Group 5: Impact of Governance Disruption - The governance disruption has led to supply chain challenges, with key customers facing delays or interruptions in product deliveries, potentially forcing them to diversify their supply chains [5] - The internal order at Nexperia has been severely impacted, with reports of halted salary payments to thousands of employees in China, creating uncertainty and anxiety within the workforce [5] Group 6: Wingtech's Call for Restoration of Rights - Wingtech emphasizes the urgency of resolving the control deadlock, warning that continued intervention could lead to irreversible losses in corporate value and employee welfare [6] - The company argues that the initial intervention by Dutch authorities was based on factual and legal errors, reflecting a bias against Chinese investors [6] - Wingtech's proposed solution is the unconditional restoration of its shareholder rights and the reinstatement of Zhang Xuezheng as CEO [6] Group 7: Broader Implications - The Nexperia case has escalated beyond commercial and legal issues, drawing attention from government entities, with China's Ministry of Commerce calling for the Dutch government to rectify its administrative interventions [7] - The ministry stresses the need for cooperation to ensure the stability of the global semiconductor supply chain [7]